A 47-year-old woman comes in with the lab printout from her annual physical. She had been telling her primary care provider for two years that something was off — fatigue that did not match her sleep, brain fog that was worsening, weight gain in the abdomen despite no real change in her diet, sex drive that had essentially disappeared. The labs ordered: a CBC, a basic metabolic panel, a lipid panel, and TSH. The TSH was 2.8 — within the standard reference range — and she was told everything looked fine. She was offered an SSRI for what was being interpreted as depression. She knew it was not depression. She was right. When we ran a real hormone panel, her free T3 was at the bottom of the range, her reverse T3 was elevated, her free testosterone was undetectable, her estradiol had dropped into early-perimenopausal territory, and her fasting insulin was 14. None of that had been measured at her physical.
This pattern is not rare. I see it weekly. The conventional outpatient hormone workup misses most of what actually drives mid-life symptoms, not because primary care providers are incompetent, but because the system they work in defines "hormone testing" much more narrowly than the physiology actually requires. This article walks through what is typically tested, what is typically missed, why, and what a real workup looks like.
What "hormone testing" usually means in conventional outpatient care
The standard hormone screen ordered at most annual physicals consists of one test: TSH. That is it. If the TSH is in the reference range (currently 0.45-4.5 in most labs), thyroid is considered "normal" and the conversation moves on. For a woman over 40 reporting menopausal symptoms, a workup might add an FSH and possibly a single estradiol, often without timing it to the cycle in a perimenopausal patient where the value has limited meaning without context.
For a man with low libido, fatigue, and erectile dysfunction, the workup commonly includes a single morning total testosterone. If the total is above the lab's lower reference cutoff (typically 264 ng/dL or so, depending on the lab), he is told his testosterone is "normal" and given a prescription for tadalafil.
Cortisol is rarely tested in primary care unless there is suspicion of frank Cushing's or Addison's. DHEA-S is rarely tested. SHBG is rarely tested. Free hormones are rarely measured. The thyroid panel almost never includes free T3, reverse T3, or thyroid antibodies. Insulin is essentially never on the panel — only HbA1c and fasting glucose, which miss insulin resistance until it has been present for years.
This is not a failure of individual providers. It is the structure of the system they work in. Insurance reimbursement, time per visit, formulary constraints, and the medico-legal preference for staying within reference ranges all push toward a minimal panel that catches frank disease and misses the optimization picture. A 12-minute visit cannot deliver a 45-minute hormone workup, and the standard panel is what fits in 12 minutes.
What gets missed when the panel is too narrow
Subclinical hypothyroidism with normal TSH. The TSH is a pituitary marker — it tells you what the pituitary thinks about thyroid status. It does not tell you what is happening at the tissue level. A patient with normal TSH can have low free T3 (the active thyroid hormone), elevated reverse T3 (an inactive metabolite that competes for receptor sites), or autoimmune thyroiditis with elevated antibodies and progressive thyroid destruction that has not yet pushed the TSH out of range. All three patterns produce real symptoms. None of them show on a TSH-only screen.
Functional testosterone deficiency in men with "normal" total testosterone. A total testosterone of 350 ng/dL is technically within the reference range. In a 45-year-old man who is symptomatic, with an SHBG of 60 binding most of that testosterone, the calculated free testosterone may be at the bottom of the optimal range or below. He is functionally deficient. The total testosterone alone does not tell you that. You need free testosterone (or calculated free, with SHBG and albumin) to see it.
Estrogen-progesterone imbalance in perimenopause. A perimenopausal woman often has estradiol levels that fluctuate dramatically across cycles while progesterone production from the corpus luteum drops earlier and more steeply. The clinical picture — anxiety, sleep disruption, breast tenderness, heavier or irregular periods, mood instability — is driven by relative estrogen excess against insufficient progesterone, not absolute deficiency of either. A single estradiol level in the middle of an unpredictable cycle, without progesterone, does not capture this.
Insulin resistance with normal glucose. Fasting insulin can be elevated for years before glucose control fails. A fasting insulin of 18 with a normal HbA1c indicates a pancreas working overtime to keep glucose in range, with all the downstream consequences of chronic hyperinsulinemia — visceral fat deposition, suppressed SHBG (which lowers free testosterone), elevated triglycerides, cardiovascular risk. The HbA1c and fasting glucose alone miss this entirely.
Cortisol pattern abnormalities. A single morning serum cortisol tells you very little. The cortisol curve across the day — high in the early morning, declining through the afternoon, lowest at bedtime — is what matters clinically. A flattened curve, an elevated evening cortisol, or a blunted morning peak each correspond to different symptom patterns and different interventions.
DHEA-S and adrenal reserve. DHEA-S declines progressively with age and is the precursor for both testosterone and estrogen production after gonadal function fails. A low DHEA-S limits the substrate available for downstream hormone production and contributes to the symptom picture. It is rarely measured in conventional workups.
Why this happens — the system, not the people
Seventeen years in emergency medicine, cardiac ICU, and the cath lab gave me a clear view of what acute medicine optimizes for. It catches the patient who is going to die in the next six hours — the MI, the sepsis, the stroke, the bleed. The system does that part very well. What it does not do well is the slow, gradient decline of mid-life — the patient whose function has dropped 30 percent over five years but whose individual lab values are all "in range." She does not die in the next six hours. The system is not built to catch her.
Primary care is structurally similar. The reimbursement model rewards diagnosis codes that fit existing categories, and "feeling worse than I should at 47" is not a reimbursable diagnosis. Reference ranges are population-based — they include the bottom 2.5 percent of values in healthy populations, which means a value can be "in range" while being meaningfully suboptimal for the individual. The testosterone lower cutoff, for example, was built from population data that included many men with subclinical deficiency, biasing it downward.
This is not a moral failing of primary care providers. It is the structure they work inside. The workaround is to ask for the labs you need explicitly, or to work with a clinic where the panel is built around physiology rather than insurance coding.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
What I order on a real first-visit hormone panel
When a new patient comes in for a hormone evaluation, I do not order a small panel and add tests later as needed. I order the full panel up front so we have the data to make a real recommendation at the second visit. The panel includes:
- Estradiol (E2), with a sensitive assay for post-menopausal women or those on transdermal therapy
- Estrone (E1) — especially in post-menopausal women
- Progesterone — timed to cycle in perimenopausal patients
- Total testosterone
- Free testosterone (calculated from total + SHBG + albumin, or measured directly)
- DHEA-S
- SHBG
- FSH and LH
- Prolactin
- TSH
- Free T3
- Free T4
- Reverse T3
- TPO antibodies and thyroglobulin antibodies
- Fasting insulin
- HbA1c
- Fasting glucose
- Comprehensive metabolic panel
- Full lipid panel including ApoB and Lp(a) where indicated
- High-sensitivity CRP
- Ferritin
- Vitamin D (25-OH)
- B12 and folate
- Homocysteine in selected patients
For some patients I add a four-point salivary cortisol curve, continuous glucose monitoring, or thyroid imaging based on antibody and physical exam findings.
Comprehensive lab work at this depth is the foundation. Without it, any conversation about hormone optimization is informed guessing.
How I read the panel
I do not read individual values against population reference ranges in isolation. I read the panel as a system. Free testosterone in the context of SHBG and total testosterone. Estradiol in the context of progesterone, FSH, and cycle position. Free T3 in the context of reverse T3, TSH, and antibody status. Insulin in the context of glucose and SHBG. The interactions tell me what is actually happening physiologically.
This is the part of the work that takes time. The second visit, where we sit with the data together and walk through what each marker means in context, is usually 45-60 minutes. By the end, the patient has the same picture I do, and the treatment plan that follows is grounded in real physiology — not a single number that fell outside a range.
What I will not do
I will not start hormone optimization on a partial panel. If a patient brings me labs that include TSH and a single estradiol and asks me to start her on hormones, I redraw the full panel before I prescribe.
I will not chase a single number. The goal is symptom relief and physiological balance, not optimizing one marker on a page while ignoring the rest of the system.
I will not dismiss a symptom because the labs look "normal." If the symptoms are real and the standard panel is unrevealing, the panel was probably the wrong panel. We expand it.
The next step
If you have been told your hormones are "normal" but you do not feel normal, the most useful next step is a panel that includes the markers your previous workup missed. You can request the full panel at either the Columbus or Warner Robins clinic, or bring recent lab work for review and we will identify what is missing. Most patients in middle Georgia — Columbus, Warner Robins, Fort Benning, surrounding communities — have access to the same labs we use, so prior results are usually compatible.
Bring everything you have to the first visit: prior labs, medication list, supplements, symptom timeline. We start with the data. If your physiology indicates hormone optimization is appropriate, we have a clear path. If something else is driving the picture — sleep apnea, untreated thyroid disease, insulin resistance, a nutritional deficiency — we identify that and address it. The point of the workup is to find what is actually there.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.